Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years and Over|
- - Any patient 18 years old or older that schedules a visit to WAGI clinics or endoscopy center.
- - Able to use electronic communications.
- - Able to communicate in English.
- - Consent to participate in the study.
Exclusion Criteria:- None
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Principal Investigator Affiliation||Viome|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
|Ulcerative Colitis, Crohn Disease, Obesity, Colon Polyp, Eosinophilic Esophagitis, GERD, Gastro Esophageal Reflux, Barrett Esophagus, Esophageal Cancer, Gastritis, Gastric Ulcer, Duodenal Ulcer, Intestinal Metaplasia, Gastric Cancer, Lymphocytic Colitis, Microscopic Colitis, Celiac Sprue, IBS, Irritable Bowel Syndrome, SIBO, NAFLD, Gallstone Disease|
This is a longitudinal, observational study whose main goal is to identify the human and microbial determinants of gastrointestinal diseases. Molecular and metadata will be collected from a large study population at multiple time points. Machine learning will be applied to all data, and models will be evaluated for development of novel diagnostic and therapeutic tools.
: Ulcerative Colitis
Participants with ulcerative colitis.
: Crohn's Disease
Participants with Crohn's disease.
Participants that are obese.
: Colon Polyps
Participants with colon polyps.
: Eosinophilic esophagitis
Participants with Eosinophilic esophagitis
: Gastroesophageal Reflux Disease (GERD)
Participants with Gastroesophageal Reflux Disease (GERD).
Participants with gastritis.
: Gastric ulcers
Participants with gastric ulcers.
: Duodenal ulcers
Participants with duodenal ulcers.
: Intestinal metaplasia
Participants with intestinal metaplasia (risk factor for esophageal cancer).
: Gastric Cancer
Participants with gastric cancer.
: Lymphocytic/Microscopic Colitis
Participants with Lymphocytic/Microscopic Colitis.
: Celiac Sprue
Participants with Celiac Sprue.
: Irritable Bowel Syndrome (IBS)
Participants with IBS.
: Small intestinal bacterial overgrowth (SIBO)
Participants with SIBO.
: Non-alcoholic Fatty Liver Disease (NAFLD)
Participants with NAFLD.
: Gallstone disease
Participants with Gallstone disease.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.